Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-02-27 @ 10:39 AM
Study NCT ID:
NCT03948035
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-06
First Post:
2018-12-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
Sponsor:
Wuerzburg University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2029-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-20
First Submit QC Date:
None
Study First Post Date:
2019-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-04
Last Update Post Date:
2023-05-06
Last Update Post Date Type:
ACTUAL